Project Grant R37CA303148
Award Date 4/29/26
Completion Date 3/31/31
Dollars Obligated $662K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Palo Alto, CA 94305, USA
Similar Awards
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a Project Grant of $642,732 under the Cancer Cause and Prevention Research program (CFDA 93.393) beginning August 1, 2025, with a completion date of July 31, 2030. The award supports research to unravel heterogeneity in endometrial cancer through integrated single-cell genotype-phenotype mapping. The project addresses the critical need to refine molecular classification, improve...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a Project Grant of $133,598.00 under the Cancer Research Manpower program (CFDA 93.398) on June 23, 2025, with completion anticipated by May 31, 2027. This award supports research aimed at developing improved chemoprevention strategies for Familial Adenomatous Polyposis (FAP), a hereditary condition characterized by polyp formation and elevated cancer risk. The principal...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Leland Stanford Junior University a Project Grant of $119,172.00 under the Cancer Research Manpower program (CFDA 93.398) to support research addressing therapeutic response in non-small cell lung cancer (NSCLC). The project, initiated August 1, 2025, and completing July 31, 2027, focuses on developing computational approaches to integrate multi-modal and multi-omics biomedical datasets for improved...
- Federal Project Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a Project Grant of $635,340 (awarded May 4, 2026, with completion targeted for April 30, 2031) under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct functional genomic dissection of lung cancer in vivo. The research delivers comprehensive analysis of tumor suppressor gene function through an integrated approach combining genetically engineered mouse models,...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a $368,294 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) for the period September 1, 2025 through August 31, 2028. This award supports the development of next-generation platforms for interrogating T cell receptor (TCR) specificity to identify and detect tumor antigens at the protein level. The project addresses a critical bottleneck in cancer...
- Federal Grant Award Summary The National Cancer Institute awarded The Leland Stanford Junior University a $584,521 Project Grant on August 8, 2025, under the Cancer Treatment Research program (CFDA 93.395) to investigate subclonal determinants of radiation response in soft tissue sarcomas. The research will deliver three primary products: (1) identification and validation of epigenetic changes, including DNA methylation and chromatin accessibility alterations, that confer radioresistance to...
- Federal Project Grant Award Summary The Leland Stanford Junior University received a $135,774 Project Grant from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398) on July 10, 2025, with a completion date of June 30, 2027. This award supports research training and investigation into tumor suppressor genes (TSGs) and the overdominant model of tumor suppression in oncogenic KRAS-driven lung adenocarcinoma. The research employs advanced molecular and...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a $357,370 Project Grant to The Leland Stanford Junior University effective May 5, 2026, through April 30, 2031, under the Cancer Treatment Research program (CFDA 93.395). The research focuses on reprogramming inflammatory cancer-associated fibroblasts (CAFs) to overcome therapeutic resistance in pancreatic ductal adenocarcinoma (PDAC). The project will deliver fundamental research investigating myeloid...
- Federal Project Grant Award Summary The National Cancer Institute (NCI), under the Cancer Research Manpower program (CFDA 93.398), awarded a $131,099 Project Grant to The Leland Stanford Junior University, effective July 1, 2025 through June 30, 2027. This award supports a comprehensive investigation of the obesity paradox phenomenon in renal cell cancer (RCC), examining how adiposity-related factors at molecular, individual, and neighborhood levels influence RCC incidence, tumor aggressiveness,...
- Federal Grant Award Summary The National Cancer Institute awarded The Johns Hopkins University a Project Grant of $130,301 under the Cancer Cause and Prevention Research program (CFDA 93.393), with an award date of September 5, 2025, and a project completion date of August 31, 2030. This award supports extensions to the Surveillance, Epidemiology, and End Results (SEER)-Medicare Database, a critical data linkage that connects Medicare claims with cancer registry enrollment data. The primary...